These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1485798)

  • 1. [Epidemiology of prostate cancer].
    Grosclaude P; Roumagnac M
    Ann Urol (Paris); 1992; 26(5):294-300. PubMed ID: 1485798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostatic cancer: some epidemiological features.
    Donn AS; Muir CS
    Bull Cancer; 1985; 72(5):381-90. PubMed ID: 3878166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prostate cancer screening (III): risk factors, natural history, course without treatment. Characteristics of detected cancers].
    Villers A; Soulié M; Haillot O; Boccon-Gibod L
    Prog Urol; 1997 Sep; 7(4):655-61. PubMed ID: 9410329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Epidemiology of prostate cancer in the Limousin area].
    Druet-Cabanac M; Colombeau P; Preux PM; Paulhac P; Vergnenegre A; Dumas JP
    Prog Urol; 2002 Apr; 12(2):226-31. PubMed ID: 12108336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The epidemiology of prostate cancer].
    Rébillard X; Tretarre B; Villers A
    Rev Prat; 2003 Dec; 53(20):2224-8. PubMed ID: 15018075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changing demography of prostate cancer in Asia.
    Sim HG; Cheng CW
    Eur J Cancer; 2005 Apr; 41(6):834-45. PubMed ID: 15808953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Epidemiology of prostatic cancer].
    Harvei S
    Tidsskr Nor Laegeforen; 1999 Oct; 119(24):3589-94. PubMed ID: 10563177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cancer of the prostate. Epidemiologic evaluation, incidence, and trends, especially in France].
    Berlie J; Rezvani A; Hacene K; Bastien H; Chauvergne J; Guerrin J; Le Commandeur J; Brunet M
    Bull Cancer; 1985; 72(5):391-404. PubMed ID: 3878167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cancer of the prostate. 1. Epidemiology].
    Mottet Auselo N; Costa P; Le Pellec L; Louis JF; Navratil H
    Prog Urol; 1995 Feb; 5(1):31-7. PubMed ID: 7536526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The epidemiology of prostate cancer part I: descriptive epidemiology.
    Brawley OW; Knopf K; Merrill R
    Semin Urol Oncol; 1998 Nov; 16(4):187-92. PubMed ID: 9858324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The epidemiology of prostate cancer--recent trends in prostate cancer incidence and mortality].
    Sata F; Umemura T; Kishi R
    Gan To Kagaku Ryoho; 2001 Feb; 28(2):184-8. PubMed ID: 11242644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The epidemiology of prostate cancer part II: the risk factors.
    Brawley OW; Knopf K; Thompson I
    Semin Urol Oncol; 1998 Nov; 16(4):193-201. PubMed ID: 9858325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of prostate cancer.
    Meikle AW; Smith JA
    Urol Clin North Am; 1990 Nov; 17(4):709-18. PubMed ID: 2219573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment.
    Edwards BK; Brown ML; Wingo PA; Howe HL; Ward E; Ries LA; Schrag D; Jamison PM; Jemal A; Wu XC; Friedman C; Harlan L; Warren J; Anderson RN; Pickle LW
    J Natl Cancer Inst; 2005 Oct; 97(19):1407-27. PubMed ID: 16204691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Epidemiology of prostatic carcinoma. From the Work Group Urology in the Munich Tumor Register].
    Hölzel D
    Fortschr Med; 1991 Sep; 109(26):521-5. PubMed ID: 1783344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Adenocarcinoma of the prostate].
    Dvorácek J
    Cas Lek Cesk; 1998 Aug; 137(17):515-21. PubMed ID: 9787503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prostate cancer screening (II): is prostate cancer a public health problem? Update of incidence and mortality figures in France from 1982 to 1990].
    Grosclaude P; Menegoz F; Schaffer P; Macé Lesec'h J; Arveux P; Le Mab G; Soulié M; Villers A
    Prog Urol; 1997 Sep; 7(4):647-54. PubMed ID: 9410328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer.
    Hammarsten J; Högstedt B
    Scand J Urol Nephrol; 2002; 36(5):330-8. PubMed ID: 12487736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer prevalence in France: time trend, situation in 2002 and extrapolation to 2012.
    Colonna M; Danzon A; Delafosse P; Mitton N; Bara S; Bouvier AM; Ganry O; Guizard AV; Launoy G; Molinie F; Sauleau EA; Schvartz C; Velten M; Grosclaude P; Tretarre B
    Eur J Cancer; 2008 Jan; 44(1):115-22. PubMed ID: 18032021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Race as an independent predictor of outcome after treatment for localized prostate cancer.
    Sohayda CJ; Kupelian PA; Altsman KA; Klein EA
    J Urol; 1999 Oct; 162(4):1331-6. PubMed ID: 10492191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.